Due to a limited supply, we are unable to accept phone calls to schedule COVID-19 vaccinations.
For the most up-to-date information, please check our COVID-19 Vaccination Website.


Additional Coronavirus Updates >


Fox Chase Cancer Center News

November 19, 2020

New Link Found Between Genetic Variant, Sexually Transmitted Infections, and Prostate Cancer Risk

PHILADELPHIA (November 19, 2020) – Sexually transmitted infections (STIs) have been linked to increased risk for several types of cancer, including prostate cancer. New research out of Fox Chase Cancer Center has shown that a history of STIs combined with a certain single-nucleotide polymorphism (SNP) associated with inflammation decreased risk for prostate cancer among a small group of Jamaican men.

November 17, 2020

Fox Chase Researcher Leads Study on Impact of Funding for American Head and Neck Society

PHILADELPHIA (November 17, 2020)—Results from a recently published study spearheaded by a Fox Chase Cancer Center researcher found that over the last 20 years, research funding provided by the American Head and Neck Society (AHNS) has generated considerable return on investment and achieved the society’s aims of furthering the trajectories of early career researchers.

November 17, 2020

Fox Chase Offering First CAR T Therapy Approved for Mantle Cell Lymphoma

PHILADELPHIA (November 17, 2020)—Patients with mantle cell lymphoma treated at Fox Chase Cancer Center will now have access to treatment with brexucabtagene autoleucel, also known as Tecartus, the first cell-based gene therapy approved by the Food and Drug Administration (FDA).

November 16, 2020

New Edition of Leading Virology Textbook Co-Authored by Two Fox Chase Researchers

PHILADELPHIA (November 16, 2020)—Two leading researchers from Fox Chase Cancer Center are co-authors of the fifth edition of Principles of Virology, the leading virology textbook for undergraduate and graduate students studying how viruses reproduce and cause disease.

November 13, 2020

Researchers Home in on Possible Combination Targets to Treat T-Acute Leukemia/Lymphoma

PHILADELPHIA (November 13, 2020) – In a recently published paper, researchers at Fox Chase Cancer Center unveiled data that suggested possible new targets for the treatment of T-acute leukemia/lymphoma (T-ALL).

November 5, 2020

Gene Editing Technology Harnessed to Identify New, Druggable Targets in Kidney Cancer

PHILADELPHIA (November 5, 2020) – Researchers at Fox Chase Cancer Center have harnessed the power of the Nobel Prize-winning CRISPR/Cas9 technology to identify cellular factors involved in resistance to sunitinib by clear cell renal cell carcinoma.

Breast cancer ribbon
November 4, 2020

Fox Chase First Cancer Center in the Northeast to Utilize New Surgical Navigation Technology for Breast Conserving Surgeries

PHILADELPHIA (November 4, 2020)—Fox Chase Cancer Center has become the first cancer center in the Northeast to feature a new tumor marker technology that has been described as the next generation of surgical navigation, one that will make breast excisional biopsies and breast-conserving surgeries more precise.

October 30, 2020

New Target Could Starve Cancer and Activate Immune System in Fight Against Pancreatic Cancer

PHILADELPHIA (October 30, 2020) – In a study released online today, researchers at Fox Chase Cancer Center have identified a new biomarker and potential novel treatment target for pancreatic ductal adenocarcinoma (PDAC) that could help starve cancer cells and allow the immune system to attack the tumor.


Connect with Fox Chase